Filing Details
- Accession Number:
- 0001209191-23-060007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-29 16:33:48
- Reporting Period:
- 2023-12-28
- Accepted Time:
- 2023-12-29 16:33:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1160308 | Savara Inc | SVRA | Pharmaceutical Preparations (2834) | 841318182 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1314773 | C Nevan Elam | One Summit Square, 1717 Langhorne Newtown Road, Suite 300 Langhorne PA 19047 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-12-28 | 1,758 | $0.82 | 64,343 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-12-28 | 12,000 | $1.59 | 76,343 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-12-28 | 40,000 | $1.23 | 116,343 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-12-28 | 93,843 | $4.71 | 22,500 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-12-28 | 1,758 | $0.00 | 1,758 | $0.82 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-12-28 | 12,000 | $0.00 | 12,000 | $1.59 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-12-28 | 40,000 | $0.00 | 40,000 | $1.23 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-07-24 | No | 4 | M | Direct | |
| 0 | 2029-12-20 | No | 4 | M | Direct | |
| 0 | 2030-12-16 | No | 4 | M | Direct |
Footnotes
- The price is a weighted average sales price. The sale prices ranged from $4.70 to $4.795. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on October 24, 2014.
- The shares subject to the option vested and became exercisable in twelve equal installments on each quarterly anniversary of December 20, 2019.
- The shares subject to the option vested and became exercisable on December 16, 2021.
Billionaire Hedge Funds
